- Glenview Capital Management’s 13F portfolio value increased from ~$4.4B to ~$4.7B this quarter.
- They increased Cigna (CI), DXC Technology (DXC), Clarivate plc (CLVT) and Alight (ALIT) while reducing Fiserv (FISV) and Amazon.com (AMZN).
- The top three individual stock stakes are Cigna (CI), Tenet Healthcare (THC), and DXC Technology (DXC). They add up to ~34% of the portfolio.
This article is part of a series that provides an ongoing
analysis of the changes made to Larry Robbins’ 13F portfolio on a quarterly
basis. It is based on Robbins’ regulatory 13F
Form filed on 2/14/2024. Please visit our Tracking
Larry Robbins’ Glenview Capital Management Portfolio article for an idea on
his investment philosophy and our previous
update for the fund’s moves during Q3 2023.
This quarter, Robbins’ 13F portfolio value increased from
~$4.4B to ~$4.7B. There are 29 positions that are significantly large. The
spreadsheet below lists those larger positions individually. The top five
individual stock stakes are Cigna (CI), Tenet Healthcare (THC), DXC Technology
(DXC), United Health Services (UHS), and Global Payments (GPN). Together they
are at ~45% of the 13F assets.
The spreadsheet below highlights changes to Robbins’ 13F
stock holdings in Q4 2023:
Source: John Vincent. Data constructed from Glenview Capital
Management’s 13F filings for Q3 2023 and Q4 2023.
No comments :
Post a Comment